Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

103.80
-1.1185-1.07%
Post-market: 103.800.00000.00%16:00 EDT
Volume:16.26K
Turnover:1.69M
Market Cap:129.75M
PE:- -
High:105.09
Open:105.09
Low:103.69
Close:104.92
52wk High:110.05
52wk Low:68.05
Shares:1.25M
Float Shares:1.25M
Volume Ratio:1.32
T/O Rate:1.30%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Oppenheimer would own Capricor Therapeutics into committee meeting

TIPRANKS
·
Jul 27

Freenome, Abbott announce FDA approval of SimpleScreen CRC

TIPRANKS
·
Jul 27

Bank of England to hold interest rates as oil price surge threatens UK economy

cityam
·
Jul 26

Press Release: Samsung Epis Holdings Reports Second Quarter and Half-year 2026 Financial Results

Dow Jones
·
Jul 24

Global Forex and Fixed Income Roundup: Market Talk

Dow Jones
·
Jul 23

Gold prices continue to hold key support as ECB leaves interest rates unchanged

Kitco
·
Jul 23

Steady unemployment gives RBA room to raise interest rates

The West Australian
·
Jul 23

Yomiuri: Japan's Basic Policy Reviewed to Ease Market 'shock'

Dow Jones
·
Jul 22

Memphasys Plans 8 Million-Share Placement on ASX

TIPRANKS
·
Jul 22

Trex Acquisition Appoints Post Oak As M&A Advisor

TIPRANKS
·
Jul 22

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.

TIPRANKS
·
Jul 21

Evofem Biosciences Updates Investors via New Presentation

TIPRANKS
·
Jul 21

3 Small-Cap ETFs With More Than 20% Upside, According to Wall Street

TIPRANKS
·
Jul 17

Amneal receives FDA approval for additional iohexol strengths, presentations

TIPRANKS
·
Jul 17

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

TIPRANKS
·
Jul 17

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

TIPRANKS
·
Jul 17

IMF warns Bank of England against cutting interest rates

cityam
·
Jul 17

Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab

TIPRANKS
·
Jul 17

Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million

Stock News
·
Jul 15

Regeneron’s dupilumab granted orphan drug designation

TIPRANKS
·
Jul 15